沃森生物：公司密切关注新技术在疫苗产品研发、制造等领域的应用

Group 1 - The company, Watson Bio (300142), is closely monitoring the application of new technologies in vaccine product research and manufacturing [1] - The company advises investors to refer to its disclosed announcements for information regarding its research and technological reserves [1]